The global gluten intolerance treatment market is slated to grow on the basis of increase in incidence of celiac diseases followed by rising awareness amongst the population about the importance of early diagnosis regarding intolerance to gluten.
Intake of a gluten-free diet is the only course of treatment in the present scenario, though research is being conducted regarding therapeutics on this count.
The companies operating in the gluten intolerance treatment market are collaborating with the government and non-government agencies to create awareness about the ill-effects of ignoring the symptoms of gluten intolerance. They are trying to reach out to the untapped geographies to have a wider consumer base under the belt.
Gluten is a protein found in rye, barley, and wheat. In case of certain individuals, immune reaction to consumption of gluten means inflammation that destroys the lining of small intestine, thereby leading to various medical complications. It also averts the absorption of certain nutrients, which is called malabsorption).
The major symptom of gluten intolerance is diarrhea. The others include fatigue, bloating, and anemia. At times, there are no noticeable symptoms. Some people may also suffer from depression, with 20% of adolescents and young adults showing prevalence.
As of now, the major course of treatment is consumption of gluten-free diet, which can aid in managing symptoms and promoting intestinal healing.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Celiac disease is amongst the common life-long disorders prevalent across the globe. The prevalence generally ranges between 0.7 and 2.9% of general population as per the National Institutes of Health.
The well-defined risk groups constitute relatives of the affected individuals and those with autoimmune comorbidities.
Research states that the symptoms of celiac disease generally subside with intake of gluten-free diet. For majority of people, following gluten-free diet heals damage in small intestine. The intake of wheat, barley, rye, and kamut and triticale thus needs to be avoided.
Need to exercise control over celiac is catalyzing the gluten intolerance treatment market.
Gluten intolerance means that one gets sick after consuming gluten (a kind of protein). He/she may also feel bloated, nauseous, or tired.
Gluten intolerance is also termed as non-celiac gluten sensitivity (NCGS). This ailment is more common in women. Some people are born with it, whereas some develop it later in their lives. Research states that 6% of the individuals based in the U.S. suffer from gluten intolerance.
Gluten intolerance, if diagnosed early, can eliminate the risk of developing complications such as thyroid. Moreover, the symptoms can range from weight gain, constipation, diarrhea, and weight loss to migraines.
Various awareness programs are being conducted in this regard, so that people can be absolved of the dire consequences of gluten intolerance.
For instance, the Gluten Intolerance Group (GIG), since 2005, has been leading the gluten-free food safety initiative, wherein it is working with the manufacturers as well as food service operators around the world to ascertain that safe, gluten-free food is served. It is a part of Chef to Plate (CTP) program.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest gluten intolerance treatment industry analysis, North America dominated the gluten sensitivity management landscape in 2023 and the scenario is expected to remain unchanged during the forecast period. This is attributed to higher rate of diagnosis of gluten intolerance followed by growing demand for advanced-level treatment.
Asia Pacific’s significant gluten intolerance treatment market growth is due to increase in healthcare expenditure by the government as well as non-government agencies to combat celiac disease.
The key players in gluten intolerance treatment market are conducting an extensive research regarding devising solutions for non-celiac gluten sensitivity.
For instance, AMYRA’s AMYNOPEP01 is an exclusive combination of exopeptidases, which has the capacity to cleave immunogenic polypeptide chains into dipeptides and single amino acids, which are categorized as safely metabolized digestion products not triggering immune responses.
Precigen ActoBio, Calypso Biotech SA, Alvine Pharmaceuticals, Inc., ImmusanT, Artielle ImmunoTherapeutics, FunZyme Biotechnologies, Innovative BioPharma, AMYRA Biotech AG, Vactech Composites Pvt. Ltd., Alba Therapeutics Corporation, PvP Biologics, Inc., and others are some of the key players covered in the gluten intolerance treatment market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 593.5 Mn |
| Market Forecast (Value) in 2034 | US$ 2.5 Bn |
| Growth Rate (CAGR) | 13.9% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Mn/Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 593.5 Mn in 2023
It is projected to grow at a CAGR of 13.9% from 2024 to 2034
Growing prevalence of celiac diseases and increase in awareness regarding early diagnosis
Celiac disease segment accounted for the largest share in 2023
North America was the dominant region in 2023
Precigen ActoBio, Calypso Biotech SA, Alvine Pharmaceuticals, Inc., ImmusanT, Artielle ImmunoTherapeutics, FunZyme Biotechnologies, Innovative BioPharma, AMYRA Biotech AG, Vactech Composites Pvt. Ltd., Alba Therapeutics Corporation, PvP Biologics, Inc., and Others
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Gluten Intolerance Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Gluten Intolerance Treatment Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Gluten Intolerance Treatment Market Analysis and Forecast, by Drug Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Drug Type, 2020-2034
6.3.1. Antihistamines
6.3.2. Epinephrine
6.4. Market Attractiveness Analysis, by Drug Type
7. Global Gluten Intolerance Treatment Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Indication, 2020-2034
7.3.1. Celiac Disease
7.3.2. Dermatitis Herpetiformis
7.3.3. Depression
7.3.4. Gluten Ataxia
7.4. Market Attractiveness Analysis, by Indication
8. Global Gluten Intolerance Treatment Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2020-2034
8.3.1. Hospital Pharmacy
8.3.2. Retail Pharmacy
8.3.3. Online Pharmacy
8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Gluten Intolerance Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Gluten Intolerance Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Drug Type, 2020-2034
10.3.1. Antihistamines
10.3.2. Epinephrine
10.4. Market Value Forecast, by Indication, 2020-2034
10.4.1. Celiac Disease
10.4.2. Dermatitis Herpetiformis
10.4.3. Depression
10.4.4. Gluten Ataxia
10.5. Market Value Forecast, by Distribution Channel, 2020-2034
10.5.1. Hospital Pharmacy
10.5.2. Retail Pharmacy
10.5.3. Online Pharmacy
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Drug Type
10.7.2. By Indication
10.7.3. By Distribution Channel
10.7.4. By Country
11. Europe Gluten Intolerance Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Drug Type, 2020-2034
11.3.1. Antihistamines
11.3.2. Epinephrine
11.4. Market Value Forecast, by Indication, 2020-2034
11.4.1. Celiac Disease
11.4.2. Dermatitis Herpetiformis
11.4.3. Depression
11.4.4. Gluten Ataxia
11.5. Market Value Forecast, by Distribution Channel, 2020-2034
11.5.1. Hospital Pharmacy
11.5.2. Retail Pharmacy
11.5.3. Online Pharmacy
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Drug Type
11.7.2. By Indication
11.7.3. By Distribution Channel
11.7.4. By Country/Sub-region
12. Asia Pacific Gluten Intolerance Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Drug Type, 2020-2034
12.3.1. Antihistamines
12.3.2. Epinephrine
12.4. Market Value Forecast, by Indication, 2020-2034
12.4.1. Celiac Disease
12.4.2. Dermatitis Herpetiformis
12.4.3. Depression
12.4.4. Gluten Ataxia
12.5. Market Value Forecast, by Distribution Channel, 2020-2034
12.5.1. Hospital Pharmacy
12.5.2. Retail Pharmacy
12.5.3. Online Pharmacy
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Drug Type
12.7.2. By Indication
12.7.3. By Distribution Channel
12.7.4. By Country/Sub-region
13. Latin America Gluten Intolerance Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Drug Type, 2020-2034
13.3.1. Antihistamines
13.3.2. Epinephrine
13.4. Market Value Forecast, by Indication, 2020-2034
13.4.1. Celiac Disease
13.4.2. Dermatitis Herpetiformis
13.4.3. Depression
13.4.4. Gluten Ataxia
13.5. Market Value Forecast, by Distribution Channel, 2020-2034
13.5.1. Hospital Pharmacy
13.5.2. Retail Pharmacy
13.5.3. Online Pharmacy
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Drug Type
13.7.2. By Indication
13.7.3. By Distribution Channel
13.7.4. By Country/Sub-region
14. Middle East & Africa Gluten Intolerance Treatment Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Drug Type, 2020-2034
14.3.1. Antihistamines
14.3.2. Epinephrine
14.4. Market Value Forecast, by Indication, 2020-2034
14.4.1. Celiac Disease
14.4.2. Dermatitis Herpetiformis
14.4.3. Depression
14.4.4. Gluten Ataxia
14.5. Market Value Forecast, by Distribution Channel, 2020-2034
14.5.1. Hospital Pharmacy
14.5.2. Retail Pharmacy
14.5.3. Online Pharmacy
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Drug Type
14.7.2. By Indication
14.7.3. By Distribution Channel
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Precigen ActoBio
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Calypso Biotech SA
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Alvine Pharmaceuticals, Inc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. ImmusanT
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Artielle ImmunoTherapeutics
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. FunZyme Biotechnologies
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Innovative BioPharma
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. AMYRA Biotech AG
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Vactech Composites Pvt. Ltd.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Alba Therapeutics Corporation
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. PvP Biologics, Inc.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Others
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
List of Tables
Table 01: Global Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Drug Type, 2020-2034
Table 02: Global Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 03: Global Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 04: Global Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 05: North America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 06: North America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Drug Type, 2020-2034
Table 07: North America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 08: North America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 09: Europe Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Drug Type, 2020-2034
Table 11: Europe Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 12: Europe Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 13: Asia Pacific Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Drug Type, 2020-2034
Table 15: Asia Pacific Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 16: Asia Pacific Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 17: Latin America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Drug Type, 2020-2034
Table 19: Latin America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 20: Latin America Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 21: Middle East & Africa Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Drug Type, 2020-2034
Table 23: Middle East & Africa Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Indication, 2020-2034
Table 24: Middle East & Africa Gluten Intolerance Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
List of Figures
Figure 01: Global Gluten Intolerance Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Gluten Intolerance Treatment Market Revenue (US$ Mn), by Drug Type, 2023
Figure 03: Global Gluten Intolerance Treatment Market Value Share, by Drug Type, 2023
Figure 04: Global Gluten Intolerance Treatment Market Revenue (US$ Mn), by Indication, 2023
Figure 05: Global Gluten Intolerance Treatment Market Value Share, by Indication, 2023
Figure 06: Global Gluten Intolerance Treatment Market Revenue (US$ Mn), by Distribution Channel, 2023
Figure 07: Global Gluten Intolerance Treatment Market Value Share, by Distribution Channel, 2023
Figure 08: Global Gluten Intolerance Treatment Market Value Share, by Region, 2023
Figure 09: Global Gluten Intolerance Treatment Market Value (US$ Mn) Forecast, 2020-2034
Figure 10: Global Gluten Intolerance Treatment Market Value Share Analysis, by Drug Type, 2023 and 2034
Figure 11: Global Gluten Intolerance Treatment Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Gluten Intolerance Treatment Market Value Share Analysis, by Indication, 2023 and 2034
Figure 13: Global Gluten Intolerance Treatment Market Attractiveness Analysis, by Indication, 2024-2034
Figure 14: Gluten Intolerance Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 15: Global Gluten Intolerance Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 16: Global Gluten Intolerance Treatment Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Gluten Intolerance Treatment Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Gluten Intolerance Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Gluten Intolerance Treatment Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Gluten Intolerance Treatment Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Gluten Intolerance Treatment Market Value Share Analysis, by Drug Type, 2023 and 2034
Figure 22: North America Gluten Intolerance Treatment Market Value Share Analysis, by Indication, 2023 and 2034
Figure 23: North America Gluten Intolerance Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 24: North America Gluten Intolerance Treatment Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Gluten Intolerance Treatment Market Attractiveness Analysis, by Indication, 2024-2034
Figure 26: North America Gluten Intolerance Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 27: Europe Gluten Intolerance Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Gluten Intolerance Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Gluten Intolerance Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Gluten Intolerance Treatment Market Value Share Analysis, by Drug Type, 2023 and 2034
Figure 31: Europe Gluten Intolerance Treatment Market Value Share Analysis, by Indication, 2023 and 2034
Figure 32: Europe Gluten Intolerance Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 33: Europe Gluten Intolerance Treatment Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Gluten Intolerance Treatment Market Attractiveness Analysis, by Indication, 2024-2034
Figure 35: Europe Gluten Intolerance Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 36: Asia Pacific Gluten Intolerance Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Gluten Intolerance Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Gluten Intolerance Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Gluten Intolerance Treatment Market Value Share Analysis, by Drug Type, 2023 and 2034
Figure 40: Asia Pacific Gluten Intolerance Treatment Market Value Share Analysis, by Indication, 2023 and 2034
Figure 41: Asia Pacific Gluten Intolerance Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 42: Asia Pacific Gluten Intolerance Treatment Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Gluten Intolerance Treatment Market Attractiveness Analysis, by Indication, 2024-2034
Figure 44: Asia Pacific Gluten Intolerance Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 45: Latin America Gluten Intolerance Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Gluten Intolerance Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Gluten Intolerance Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Gluten Intolerance Treatment Market Value Share Analysis, by Drug Type, 2023 and 2034
Figure 49: Latin America Gluten Intolerance Treatment Market Value Share Analysis, by Indication, 2023 and 2034
Figure 50: Latin America Gluten Intolerance Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 51: Latin America Gluten Intolerance Treatment Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Gluten Intolerance Treatment Market Attractiveness Analysis, by Indication, 2024-2034
Figure 53: Latin America Gluten Intolerance Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 54: Middle East & Africa Gluten Intolerance Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Gluten Intolerance Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Gluten Intolerance Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Gluten Intolerance Treatment Market Value Share Analysis, by Drug Type, 2023 and 2034
Figure 58: Middle East & Africa Gluten Intolerance Treatment Market Value Share Analysis, by Indication, 2023 and 2034
Figure 59: Middle East & Africa Gluten Intolerance Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 60: Middle East & Africa Gluten Intolerance Treatment Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Gluten Intolerance Treatment Market Attractiveness Analysis, by Indication, 2024-2034
Figure 62: Middle East & Africa Gluten Intolerance Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Gluten Intolerance Treatment Market
